A detailed history of Pictet Asset Management Holding Sa transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,479,491 shares of XENE stock, worth $66.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,479,491
Previous 1,515,426 2.37%
Holding current value
$66.5 Million
Previous $65.2 Million 11.58%
% of portfolio
0.07%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$36.25 - $43.75 $1.3 Million - $1.57 Million
-35,935 Reduced 2.37%
1,479,491 $57.7 Million
Q1 2024

May 14, 2024

SELL
$42.66 - $50.04 $22.4 Million - $26.3 Million
-524,974 Reduced 25.73%
1,515,426 $65.2 Million
Q4 2023

Feb 13, 2024

BUY
$28.7 - $46.46 $2.92 Million - $4.72 Million
101,621 Added 5.24%
2,040,400 $94 Million
Q3 2023

Nov 14, 2023

BUY
$34.16 - $39.73 $66.2 Million - $77 Million
1,938,779 New
1,938,779 $66.2 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.8B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.